Bayer (OTCPK:BAYZF) (OTCPK:BAYRY) announced Thursday that elinzanetant, its experimental therapy for hot flashes, reached the ...
On the occasion of the 43rd J.P. Morgan Healthcare Conference in San Francisco, Bayer AG announces further progress in its pharmaceutical growth strategy with multiple regulatory filing submissions ...
The results suggest Bayer’s elinzanetant may help a broader group of women with vasomotor symptoms, which are associated with ...
German pharma group Bayer has made another play in the digital medical imaging category, buying Blackford Analysis and its artificial intelligence-based platform for radiological assessments.
Bemdaneprocel will be studied in a sham-surgery controlled, double-blind trial that is expected to start in the first half of ...
Gadoquatrane, a contrast agent Bayer is developing for use in MRI scans, like those done in MS, uses 60% less gadolinium and ...
As we usher in 2025, it’s the perfect time to prioritize health and wellness. Recently, Registered Dietitian & Nutritionist Kelly Bristow from Bayer, one of the country's largest lif ...
The pharmaceutical company’s latest partnership with Incremental and Skai drove a 32% boost in iROI, delivering nearly a ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback